CLGN
$18.00
Collplant Biotechnologies Ltd ADR
$.29
1.64%
CLGN
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.26)
Revenue:  $0.34 Mil
Thursday
Feb 17
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CLGN reports earnings?
Beat
Meet
Miss

Where is CLGN's stock price going from here?
Up
Flat
Down
Stock chart of CLGN
Analysts
Summary of analysts' recommendations for CLGN
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw as CollPlant Holdings Ltd., is based in Rehovot, Israel.